/ /

CLINICAL

Investigative eczema drug shows positive phase 2 resultsUK-based Ziarco Pharma Ltd. recently announced positive phase 2a results for ZPL-389, a once daily oral histamine H4 receptor antagonist, for the treatment of moderate to severe atopic dermatitis.
Dupilumab demonstrates promising resultsThe systemic therapy dupilumab met primary endpoints in two phase 3 studies on adults with in inadequately controlled moderate-to-severe atopic dermatitis.
New research focuses on B lymphocytes in psoriasisResearchers at the University of W├╝rzburg in Bavaria, Germany, are focusing their psoriasis research on a cell type that has received little attention in connection with the skin disease: B lymphocytes.
4 steps to beating blepharitisBlepharitis is an inflammatory condition of the eyelids leading to red, irritated, itchy, and dandruff-like scales that form on the eyelashes.
Insurers make prescribing biologics difficultA new study suggests that insurance coverage of biologics for psoriasis is becoming more challenging. The need for prior authorization is increasing, as are the average time from prior authorization submission to coverage decisions and prior authorization denial rates.
Making strides in support for psoriasis patientsThe National Psoriasis Foundation seeks support for initiatives that will provide better access for psoriasis patients to effectively treat their disease.
Alternative therapies hold promise for rosaceaSome unconventional therapies for rosacea get to the root of the problem, with apparent positive impacts on inflammation, skin barrier dysfunction and vascular function.
14 tips for more effective acne consultsResearchers reveal that patients may have concerns with acne consultations. The authors offer tips to improve acne consults.
Acne nuances in patients with skin of colorAcne presents with certain nuances in darker skin patients. Exacerbating factors, treatment approaches and desired treatment outcomes may differ from lighter skin patients.
Solving the ineffective acne consultResearchers report on survey findings that shed light on why patients find acne consultations ineffective.

Poll

View Results